WALTHAM, Mass., Jan. 27 /PRNewswire-FirstCall/ -- Thermo Electron
Corporation (NYSE: TMO) announced that it will present at the Merrill Lynch
Global Pharmaceutical, Biotechnology & Medical Device Conference. The company
will present on Tuesday, February 7, 2006, at 1:40 p.m. (ET) at the Grand
Hyatt in New York.
Marijn E. Dekkers, president and chief executive officer of Thermo
Electron, will give an overview of the company and discuss its expectations
for future performance.
Mr. Dekkers' presentation will be Webcast live on our Website at
http://www.thermo.com. You may listen to the Webcast by clicking on "About
Thermo," then "Investors." An audio archive of the presentation will be
available in that section of our Website under "Presentations" until Tuesday,
February 21, 2006.
About Thermo Electron
Thermo Electron Corporation is the world leader in analytical instruments.
Our instrument solutions enable our customers to make the world a healthier,
cleaner and safer place. Thermo's Life and Laboratory Sciences segment
provides analytical instruments, scientific equipment, services and software
solutions for life science, drug discovery, clinical, environmental and
industrial laboratories. Thermo's Measurement and Control segment is dedicated
to providing analytical instruments used in a variety of manufacturing
processes and in-the-field applications, including those associated with
safety and homeland security. For more information, visit
http://www.thermo.com.
Media Contact Information: Investor Contact Information:
Lori Gorski Kenneth J. Apicerno
Phone: 781-622-1242 Phone: 781-622-1111
E-mail: lori.gorski@thermo.com E-mail: ken.apicerno@thermo.com
Website: http://www.thermo.com
SOURCE Thermo Electron Corporation
 back to top
Related links:
http://www.thermo.com
Company News On-Call:
http://www.prnewswire.com/comp/877850.html
CONTACT:
Media: Lori Gorski, +1-781-622-1242,
lori.gorski@thermo.com, or Investor: Kenneth J. Apicerno,
+1-781-622-1111, ken.apicerno@thermo.com, both of Thermo
|
